PharVision Advisers’s Hayward Holdings HAYW Stock Holding History

PharVision Advisers’s Portfolio HAYW Stock Details HAYW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,458	Closed	-$285K	–	340
2025 Q4	$285K	Buy	+18,458	New	+$292K	0.14%	300

Other funds holding HAYW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

PharVision Advisers's HAYW Position: Q1 2026 in Review

PharVision Advisers sold out of Hayward Holdings (HAYW) in Q1 2026, closing a stake of 18,458 shares — an estimated $285K sold.

PharVision Advisers first reported a position in HAYW in Q4 2025 and held it in 1 quarter. The position peaked at $285K in Q4 2025. 299 funds tracked by Wall St. Rank hold HAYW as of Q1 2026.

PharVision Advisers reported no remaining Hayward Holdings position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 18,458 Hayward Holdings shares in Q1 2026, an estimated $285K.
PharVision Advisers first reported a position in Hayward Holdings in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Hayward Holdings position peaked at $285K in Q4 2025.
299 funds tracked by Wall St. Rank held Hayward Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.